Volcano Therapeutics Names Scott Huennekens As President & CEO

    LAGUNA NIGUEL, Calif., July 1 /PRNewswire/ -- Volcano Therapeutics, Inc.
 an early stage medical device company today announced it has hired medical
 industry executive Scott Huennekens as President and CEO.  Mr. Huennekens
 brings over 10 years of experience in cardiovascular disease and minimally
 invasive medical devices to Volcano.  Volcano Therapeutics is focused on the
 discovery, development and commercialization of products for the detection and
 treatment of vulnerable plaques located in the coronary or peripheral
 arteries.
     Olav Bergheim, Volcano Chairman of the Board, commented, "Scott combines
 strong leadership and communication skills with a solid track record in the
 medical device industry.  On behalf of all the board members, we are very
 pleased to have found someone with Scott's breadth of experience in
 cardiovascular disease as well as start-up to multi-national companies."
     Mr. Huennekens added, "In the U.S., each year over 500,000 people die from
 heart attacks caused primarily from vulnerable plaques, approximately a person
 every minute.  Volcano has a vision of significantly reducing the number of
 heart attacks through technological developments and strong relationships with
 our clinical partners.  Given Volcano's single minded focus on vulnerable
 plaques and broad base of diagnostic and therapeutic technologies in
 development, we are well-positioned to be first in developing solutions that
 will meet significant unmet clinical needs and help thousands of people."
     Prior to joining Volcano, Mr. Huennekens was the President and CEO of
 Digirad Corp, the leader in solid-state nuclear cardiology imaging.  At
 Digirad, he was responsible for raising over $60M of venture capital and
 moving the company from the product development phase to product
 commercialization.  As CEO, he led the company's growth from 45 to
 300+ employees and revenue from $7M to $32M in 2001.  Prior to Digirad, he was
 at Baxter Healthcare in their Cardiovascular Group where he held various
 sales, marketing, and general management positions.  Huennekens holds a
 Bachelor of Science in Business Administration from University of Southern
 California and a Masters in Business Administration from Harvard Graduate
 School of Business.
 
     About Volcano Therapeutics
     Volcano Therapeutics, Inc., a privately held early stage medical device
 with headquarters in Laguna Hills, CA, was founded in 2001.  Volcano is
 focused on the discovery, development and commercialization of products for
 the detection and treatment of vulnerable plaque in the coronary arteries and
 peripheral vascular system.  Currently under development are technologies that
 could be potentially useful in detecting and treating patients who are at risk
 for developing plaque rupture and subsequent adverse cardiac events.  For more
 information, please visit us at www.volcanotherapeutics.com .
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X33419146
 
 

SOURCE  Volcano Therapeutics, Inc.